To evaluate the stemness of the GBM cell populations in different regions of the tumors, we undertook ALDH1 and Nestin immunohistochemistry, using a semi-quantified scale of increasing intensity (−,+,++,+++). This evidence concerns the gene ALDH1A1 and glioblastoma.